Loss of PTEN expression by dermal fibroblasts causes skin fibrosis

Journal of Investigative Dermatology

Volumn 131, Issue 10, 2011, Pages 1996-2003

  Parapuram, Sunil K ^a   Shi Wen, Xu ^b   Elliott, Christopher ^a   Welch, Ian D ^a   Jones, Helen ^b   Baron, Murray ^c   Denton, Christopher P ^b   Abraham, David J ^b   Leask, Andrew ^a  

^a WESTERN UNIVERSITY   (Canada)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; CONNECTIVE TISSUE GROWTH FACTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; FEMALE; FIBROGENESIS; GENE DELETION; HUMAN; HUMAN CELL; IN VIVO STUDY; MAJOR CLINICAL STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN FIBROBLAST; SKIN FIBROSIS; SKINFOLD THICKNESS; SYSTEMIC SCLEROSIS;

EID: 80052863290     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2011.156     Document Type: Article

References (37)

1. Abraham DJ, Krieg T, Distler J et al. (2009) Overview of pathogenesis of systemic sclerosis. Rheumatology (Oxford) 48(Suppl 3):iii3-7
2. Arcaro A, Wymann MP (1993) Wortmannin is a potent phosphatidylinositol 3-kinase inhibitor: the role of phosphatidylinositol 3,4,5-trisphosphate in neutrophil responses. Biochem J 296(Part 2):297-301 (Pubitemid 23350826)
3. Cai CL, Martin JC, Sun Y et al. (2008) A myocardial lineage derives from Tbx18 epicardial cells. Nature 454:104-8 (Pubitemid 351931969)
4. Carnero A (2010) The PKB/AKT pathway in cancer. Curr Pharm Des 16:34-44
5. Chen Y, Shi-wen X, van Beek JKennedy L et al. (2005) Matrix contraction by dermal fibroblasts requires TGFbeta/ALK5, heparan sulfate containing proteoglycans and MEK/ERK: insights into pathological scarring in chronic fibrotic disease. Am J Pathol 167:1699-711 (Pubitemid 41713321)
6. Chen Y, Shi-wen X, Eastwood M et al. (2006) Contribution of activin receptorlike kinase 5 (transforming growth factor beta receptor type I) signaling to the fibrotic phenotype of scleroderma fibroblasts. Arthritis Rheum 54:1309-16 (Pubitemid 43672944)
7. Groszer M, Erickson R, Scripture-Adams DD et al. (2001) Negative regulation of neural stem/progenitor cell proliferation by the Pten tumor suppressor gene in vivo. Science 294:2186-9 (Pubitemid 33150679)
8. Hao LS, Zhang XL, An JY et al. (2009) PTEN expression is down-regulated in liver tissues of rats with hepatic fibrosis induced by biliary stenosis. APMIS 117:681-91
9. Inman GJ, Nicolás FJ, Callahan JF et al. (2002) SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Mol Pharmacol 62:65-74 (Pubitemid 34680517)
10. Ishida W, Mori Y, Lakos G et al. (2006) Intracellular TGF-beta receptor blockade abrogates Smad-dependent fibroblast activation in vitro and in vivo. J Invest Dermatol 126:1733-44 (Pubitemid 44086506)
11. Jun JB, Kuechle M, Min J et al. (2005) Scleroderma fibroblasts demonstrate enhanced activation of Akt (protein kinase B) in situ. J Invest Dermatol 124:298-303 (Pubitemid 40175874)
12. Kato M, Putta S, Wang M et al. (2009) TGF-beta activates Akt kinase through a microRNA-dependent amplifying circuit targeting PTEN. Nat Cell Biol 11:881-9
13. Leask A (2010) Towards an anti-fibrotic therapy for scleroderma: targeting myofibroblast differentiation and recruitment. Fibrogenesis Tissue Repair 3:8
14. Leask A (2011) Possible strategies in antifibrotic drug intervention in scleroderma. J Cell Commun Signal 5:125-9
15. Leask A, Parapuram SK, Shi-Wen X et al. (2009) Connective tissue growth factor (CTGF, CCN2) gene regulation: a potent clinical bio-marker of fibroproliferative disease? J Cell Commun Signal 3:89-94
16. LeRoy EC, Black C, Fleischmajer R et al. (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15:202-5 (Pubitemid 18073738)
17. Lesche R, Groszer M, Gao J et al. (2002) Cre/loxP-mediated inactivation of the murine Pten tumor suppressor gene. Genesis 32:148-9 (Pubitemid 34211723)
18. Liu S, Kapoor M, Leask A (2009) Rac1 expression by fibroblasts is required for tissue repair in vivo. Am J Pathol 174:1847-56
19. Liu S, Kapoor M, Shi-wen X et al. (2008) Investigation of the role of Rac1 in a bleomycin-induced scleroderma model using fibroblast-specific Rac1 knockout mice. Arthritis Rheum 58:2189-95 (Pubitemid 351988113)
20. Lu Y, Azad N, Wang L et al. (2010) Phosphatidylinositol-3-kinase/akt regulates bleomycin-induced fibroblast proliferation and collagen production. Am J Respir Cell Mol Biol 42:432-41
21. Pala D, Kapoor M, Woods A et al. (2008) Focal adhesion kinase/Src suppresses early chondrogenesis: central role of CCN2. J Biol Chem 283:9239-47
22. Samuel CS (2009) Determination of collagen content, concentration and subtypes in kidney tissue from: methods in molecular biology. In: Hewitson TD, Becker GJ (eds), Kidney Research, vol. 466. Humana Press: Totowa, NJ
23. Sargent JL, Milano A, Bhattacharyya S et al. (2010) A TGFbeta-responsive gene signature is associated with a subset of diffuse scleroderma with increased disease severity. J Invest Dermatol 130:694-705
24. Sellers LA, Alderton F, Carruthers AM et al. (2000) Receptor isoforms mediate opposing proliferative effects through gbetagamma-activated p38 or Akt pathways. Mol Cell Biol 20:5974-85 (Pubitemid 30613046)
25. Shi-Wen X, Chen Y, Denton CP et al. (2004) Endothelin-1 promotes myofibroblast induction through the ETA receptor via a rac/phosphoi-nositide 3-kinase/Akt-dependent pathway and is essential for the enhanced contractile phenotype of fibrotic fibroblasts. Mol Biol Cell 15:2707-19 (Pubitemid 38691860)
26. Shi-wen X, Denton CP, McWhirter A et al. (1997) Scleroderma lung fibroblasts exhibit elevated and dysregulated collagen type I biosynthesis. Arthritis Rheum 40:1237-44 (Pubitemid 27430134)
27. Shi-wen X, Liu S, Eastwood M et al. (2009) Rac inhibition reverses the phenotype of fibrotic fibroblasts. PLoS One 4:e7438
28. Shi-Wen X, Renzoni EA, Kennedy L et al. (2006) Endogenous endothelin-1 signaling contributes to type I collagen and CCN2 overexpression in fibrotic fibroblasts. Matrix Biol 26:625-32 (Pubitemid 350186096)
29. Shi-wen X, Pennington D, Holmes A et al. (2000) Autocrine overexpression of CTGF maintains fibrosis: RDA analysis of fibrosis in systemic sclerosis. Exp Cell Res 259:213-24
30. Teresi RE, Waite KA (2008) PPARgamma, PTEN, and the fight against cancer. PPAR Res 2008:932632
31. Trojanowska M (2009) Noncanonical transforming growth factor beta signaling in scleroderma fibrosis. Curr Opin Rheumatol 21: 623-9
32. Tsugawa K, Jones MK, Sugimachi K et al. (2002) Biological role of phosphatase PTEN in cancer and tissue injury healing. Front Biosci 7:e245-51
33. Wei J, Ghosh AK, Sargent JL et al. (2010) PPARg downregulation by TGFb in fibroblast and impaired expression and function in systemic sclerosis: a novel mechanism for progressive fibrogenesis. PLoS One 5:e13778
34. Xia H, Diebold D, Nho R et al. (2008) Pathological integrin signaling enhances proliferation of primary lung fibroblasts from patients with idiopathic pulmonary fibrosis. J Exp Med 205:1659-72 (Pubitemid 351962029)
35. Yang Y, Zhou F, Fang Z et al. (2009) Post-transcriptional and post-translational regulation of PTEN by transforming growth factor-beta1. J Cell Biochem 106:1102-12
36. Young AT, Dahl J, Hausdorff SF et al. (1995) Phosphatidylinositol 3-kinase binding to polyoma virus middle tumor antigen mediates elevation of glucose transport by increasing translocation of the GLUT1 transporter. Proc Natl Acad Sci USA 92:11613-7 (Pubitemid 26014163)
37. Zheng B, Zhang Z, Black CM et al. (2002) Ligand-dependent genetic recombination in fibroblasts: a potentially powerful technique for investigating gene function in fibrosis. Am J Pathol 160: 1609-17 (Pubitemid 34525641)